Revitalising Aging Oocytes: Echinacoside Restores Mitochondrial Function and Cellular Homeostasis Through Targeting GJA1/SIRT1 Pathway

Abstract

As maternal age increases, the decline in oocyte quality emerges as a critical factor contributing to reduced reproductive capacity, highlighting the urgent need for effective strategies to combat oocyte aging. This study investigated the protective effects and underlying mechanisms of Echinacoside (ECH) on aging oocytes. ECH significantly improved cytoskeletal stability and chromosomal integrity, as demonstrated by restored spindle morphology and reinforced F-actin structures, essential for meiotic progression. It also preserved mitochondrial function by restoring membrane potential and dynamics, reducing ROS levels, and downregulating the DNA damage marker γ-H2AX, thereby alleviating oxidative stress and enhancing genomic stability. Furthermore, ECH promoted cellular homeostasis through modulation of lipid metabolism, autophagy and lysosomal function. Transcriptomic analyses identified GJA1 as a pivotal mediator of ECH's effects, validated through molecular docking and bio-layer interferometry. Functional studies showed that inhibiting GJA1 significantly reduced ECH's ability to enhance first polar body extrusion rates, mitochondrial function and antioxidant capacity, validating the critical role of the GJA1/SIRT1 pathway in combating oocyte aging. This study provides novel insights into the mechanisms of oocyte rejuvenation and highlights ECH as a promising therapeutic candidate for addressing age-related reproductive challenges.

Keywords

cellular homeostasis / echinacoside / GJA1/SIRT1 pathway / mitochondrial function / oocyte aging / oxidative stress

References

[1] K. Neels, M. Murphy, N. B. M, and É. Beaujouan, “Rising Educational Participation and the Trend to Later Childbearing,” Population and Development Review 43, no. 4 (2017): 667-693, https://doi.org/10.1111/padr.12112.

[2] I. M. Timæus and T. A. Moultrie, “Pathways to Low Fertility: 50 Years of Limitation, Curtailment, and Postponement of Childbearing,” Demography 57, no. 1 (2020): 267-296.

[3] H. Cheng, W. Luo, S. Si, et al., “Global Trends in Total Fertility Rate and Its Relation to National Wealth, Life Expectancy and Female Education,” BMC Public Health 22, no. 1 (2022): 1346.

[4] E. Beaujouan, “Latest-Late Fertility? Decline and Resurgence of Late Parenthood Across the Low-Fertility Countries,” Population and Development Review 46, no. 2 (2020): 219-247.

[5] M. S. Schimmel, R. Bromiker, C. Hammerman, et al., “The Effects of Maternal Age and Parity on Maternal and Neonatal Outcome,” Archives of Gynecology and Obstetrics 291, no. 4 (2015): 793-798.

[6] Z. Kmietowicz, “Average Age of Starting Fertility Treatment Rises to Over 35 in UK,” British Medical Journal 386 (2024): q1591.

[7] A. P. Cil, L. Turkgeldi, and E. Seli, “Oocyte Cryopreservation as a Preventive Measure for Age-Related Fertility Loss,” Seminars in Reproductive Medicine 33, no. 6 (2015): 429-435.

[8] I. Glick, E. Kadish, and M. Rottenstreich, “Management of Pregnancy in Women of Advanced Maternal Age: Improving Outcomes for Mother and Baby,” International Journal of Women's Health 13 (2021): 751-759.

[9] J. M. Franasiak, E. J. Forman, K. H. Hong, et al., “The Nature of Aneuploidy With Increasing Age of the Female Partner: A Review of 15,169 Consecutive Trophectoderm Biopsies Evaluated With Comprehensive Chromosomal Screening,” Fertility and Sterility 101, no. 3 (2014): 656-663.e1.

[10] E. E. Telfer, J. Grosbois, Y. L. Odey, R. Rosario, and R. A. Anderson, “Making a Good Egg: Human Oocyte Health, Aging, and In Vitro Development,” Physiological Reviews 103, no. 4 (2023): 2623-2677.

[11] A. R. Eftekhari Moghadam, G. Saki, M. Hemadi, Z. Mazaheri, and A. Khodadadi, “Effect of Dehydroepiandrosterone on Meiotic Spindle Structure and Oocyte Quality in Mice,” Iranian Journal of Basic Medical Sciences 21, no. 10 (2018): 1020-1025.

[12] A. R. E. Moghadam, M. T. Moghadam, M. Hemadi, and G. Saki, “Oocyte Quality and Aging,” JBRA Assisted Reproduction 26, no. 1 (2022): 105-122.

[13] V. Desquiret-Dumas, A. Clément, V. Seegers, et al., “The Mitochondrial DNA Content of Cumulus Granulosa Cells Is Linked to Embryo Quality,” Human Reproduction 32, no. 3 (2017): 607-614.

[14] A. Kirillova, J. E. J. Smitz, G. T. Sukhikh, and I. Mazunin, “The Role of Mitochondria in Oocyte Maturation,” Cells 10, no. 9 (2021): 2484.

[15] L. Yang, Y. Chen, Y. Liu, et al., “The Role of Oxidative Stress and Natural Antioxidants in Ovarian Aging,” Frontiers in Pharmacology 11 (2020): 617843.

[16] W. Wang, S. Jiang, Y. Zhao, and G. Zhu, “Echinacoside: A Promising Active Natural Products and Pharmacological Agents,” Pharmacological Research 197 (2023): 106951.

[17] J. Li, H. Yu, C. Yang, T. Ma, and Y. Dai, “Therapeutic Potential and Molecular Mechanisms of Echinacoside in Neurodegenerative Diseases,” Frontiers in Pharmacology 13 (2022): 841110.

[18] J. Han, Y. Sun, T. Wu, et al., “Echinacoside-Zinc Nanomaterial Inhibits Skin Glycation by Suppressing the Transcriptional Activation of the Receptor for Advanced Glycation End-Products,” ACS Nano 17, no. 14 (2023): 14123-14135.

[19] J. Wei, Z. Zheng, X. Hou, et al., “Echinacoside Inhibits Colorectal Cancer Metastasis via Modulating the Gut Microbiota and Suppressing the PI3K/AKT Signaling Pathway,” Journal of Ethnopharmacology 318, no. Pt A (2024): 116866.

[20] Z. Jiang, B. Zhou, X. Li, G. M. Kirby, and X. Zhang, “Echinacoside Increases Sperm Quantity in Rats by Targeting the Hypothalamic Androgen Receptor,” Scientific Reports 8, no. 1 (2018): 3839.

[21] Y. Ni, J. Deng, X. Liu, et al., “Echinacoside Reverses Myocardial Remodeling and Improves Heart Function via Regulating SIRT1/FOXO3a/MnSOD Axis in HF Rats Induced by Isoproterenol,” Journal of Cellular and Molecular Medicine 25, no. 1 (2021): 203-216.

[22] F. Dai, R. Wang, Z. Deng, et al., “Comparison of the Different Animal Modeling and Therapy Methods of Premature Ovarian Failure in Animal Model,” Stem Cell Research & Therapy 14, no. 1 (2023): 135.

[23] S. Zhao, N. Heng, H. Wang, et al., “Mitofusins: From Mitochondria to Fertility,” Cellular and Molecular Life Sciences 79, no. 7 (2022): 370.

[24] D. B. Zorov, M. Juhaszova, and S. J. Sollott, “Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release,” Physiological Reviews 94, no. 3 (2014): 909-950.

[25] A. Ballabio and J. S. Bonifacino, “Lysosomes as Dynamic Regulators of Cell and Organismal Homeostasis,” Nature Reviews. Molecular Cell Biology 21, no. 2 (2020): 101-118.

[26] A. E. Peters, B. P. Mihalas, E. G. Bromfield, S. D. Roman, B. Nixon, and J. M. Sutherland, “Autophagy in Female Fertility: A Role in Oxidative Stress and Aging,” Antioxidants & Redox Signaling 32, no. 8 (2020): 550-568.

[27] C. Nithya, M. Kiran, and H. A. Nagarajaram, “Dissection of Hubs and Bottlenecks in a Protein-Protein Interaction Network,” Computational Biology and Chemistry 102 (2023): 107802.

[28] A. Rodríguez-Sinovas, M. Ruiz-Meana, A. Denuc, and D. García-Dorado, “Mitochondrial Cx43, an Important Component of Cardiac Preconditioning,” Biochimica et Biophysica Acta - Biomembranes 1860, no. 1 (2018): 174-181.

[29] J. Zhang, M. A. Riquelme, R. Hua, F. M. Acosta, S. Gu, and J. X. Jiang, “Connexin 43 Hemichannels Regulate Mitochondrial ATP Generation, Mobilization, and Mitochondrial Homeostasis Against Oxidative Stress,” eLife 11 (2022): e82206.

[30] R. Kar, M. A. Riquelme, S. Werner, and J. X. Jiang, “Connexin 43 Channels Protect Osteocytes Against Oxidative Stress-Induced Cell Death,” Journal of Bone and Mineral Research 28, no. 7 (2013): 1611-1621.

[31] J. D. Iljas, Z. Wei, and H. A. Homer, “Sirt1 Sustains Female Fertility by Slowing Age-Related Decline in Oocyte Quality Required for Post-Fertilization Embryo Development,” Aging Cell 19, no. 9 (2020): e13204.

[32] X. Sun, K. Huang, X. Haiming, et al., “Connexin 43 Prevents the Progression of Diabetic Renal Tubulointerstitial Fibrosis by Regulating the SIRT1-HIF-1α Signaling Pathway,” Clinical Science (London, England) 134, no. 13 (2020): 1573-1592.

[33] A. Remigante, S. Spinelli, E. Straface, et al., “Açaì (Euterpe oleracea) Extract Protects Human Erythrocytes From Age-Related Oxidative Stress,” Cells 11, no. 15 (2022): 2391.

[34] A. Remigante, S. Spinelli, N. Basile, et al., “Oxidation Stress as a Mechanism of Aging in Human Erythrocytes: Protective Effect of Quercetin,” International Journal of Molecular Sciences 23, no. 14 (2022): 7781.

[35] D. Hu, Y. Ge, L. Ye, et al., “D-Galactose Induces the Senescence and Phenotype Switch of Corpus Cavernosum Smooth Muscle Cells,” Journal of Cellular Physiology 239, no. 1 (2024): 124-134.

[36] D. Adhikari, I. W. Lee, W. S. Yuen, and J. Carroll, “Oocyte Mitochondria-Key Regulators of Oocyte Function and Potential Therapeutic Targets for Improving Fertility,” Biology of Reproduction 106, no. 2 (2022): 366-377.

[37] Y. Morimoto, U. S. K. Gamage, T. Yamochi, et al., “Mitochondrial Transfer Into Human Oocytes Improved Embryo Quality and Clinical Outcomes in Recurrent Pregnancy Failure Cases,” International Journal of Molecular Sciences 24, no. 3 (2023): 2738.

[38] C. N. Okoye, S. A. Koren, and A. P. Wojtovich, “Mitochondrial Complex I ROS Production and Redox Signaling in Hypoxia,” Redox Biology 67 (2023): 102926.

[39] J. Song, L. Xiao, Z. Zhang, et al., “Effects of Reactive Oxygen Species and Mitochondrial Dysfunction on Reproductive Aging,” Frontiers in Cell and Development Biology 12 (2024): 1347286.

[40] J. Gómez, N. Mota-Martorell, M. Jové, R. Pamplona, and G. Barja, “Mitochondrial ROS Production, Oxidative Stress and Aging Within and Between Species: Evidences and Recent Advances on This Aging Effector,” Experimental Gerontology 174 (2023): 112134.

[41] J. Kruk, H. Y. Aboul-Enein, A. Kładna, and J. E. Bowser, “Oxidative Stress in Biological Systems and Its Relation With Pathophysiological Functions: The Effect of Physical Activity on Cellular Redox Homeostasis,” Free Radical Research 53, no. 5 (2019): 497-521.

[42] Y. Aman, T. Schmauck-Medina, M. Hansen, et al., “Autophagy in Healthy Aging and Disease,” Nature Aging 1, no. 8 (2021): 634-650.

[43] N. Peker and D. Gozuacik, “Autophagy as a Cellular Stress Response Mechanism in the Nervous System,” Journal of Molecular Biology 432, no. 8 (2020): 2560-2588.

[44] S. S. Hu, T. Y. Wang, L. Ni, et al., “Icariin Ameliorates D-Galactose-Induced Cell Injury in Neuron-Like PC12 Cells by Inhibiting MPTP Opening,” Current Medical Science 44, no. 4 (2024): 748-758.

[45] Y. Xu, Y. Li, L. Ma, et al., “D-Galactose Induces Premature Senescence of Lens Epithelial Cells by Disturbing Autophagy Flux and Mitochondrial Functions,” Toxicology Letters 289 (2018): 99-106.

[46] R. M. Irwin, M. A. Thomas, M. J. Fahey, M. D. Mayán, J. W. Smyth, and M. L. Delco, “Connexin 43 Regulates Intercellular Mitochondrial Transfer From Human Mesenchymal Stromal Cells to Chondrocytes,” Stem Cell Research & Therapy 15, no. 1 (2024): 359.

[47] K. Boengler, L. Leybaert, M. Ruiz-Meana, and R. Schulz, “Connexin 43 in Mitochondria: What Do we Really Know About Its Function?,” Frontiers in Physiology 13 (2022): 928934.

[48] A. K. Singh, K. Golan, M. J. Althoff, et al., “Connexin-43 Is a Negative Regulator of Mitochondrial Fission, Mitophagy and Apoptosis of Dividing Hematopoietic Stem Cells Through the Drp1-Pink1 Axis,” Blood 132, no. Supplement 1 (2018): 639.

[49] H. Zhang, W. Su, R. Zhao, et al., “Epigallocatechin-3-Gallate Improves the Quality of Maternally Aged Oocytes,” Cell Proliferation 57, no. 4 (2024): e13575.

[50] Y. Luo, J. Li, L. Zheng, et al., “Procyanidin B2 Improves Developmental Capacity of Bovine Oocytes via Promoting PPARγ/UCP1-Mediated Uncoupling Lipid Catabolism During In Vitro Maturation,” Cell Proliferation 57, no. 11 (2024): e13687.

RIGHTS & PERMISSIONS

2025 The Author(s). Cell Proliferation published by Beijing Institute for Stem Cell and Regenerative Medicine and John Wiley & Sons Ltd.